Ulmer Michelle, Robinaugh Donald, Friedberg Jennifer P, Lipsitz Stuart R, Natarajan Sundar
VA New York Harbor Healthcare System, New York, NY, USA.
Contemp Clin Trials. 2008 Sep;29(5):705-10. doi: 10.1016/j.cct.2008.04.005. Epub 2008 May 6.
We evaluated the usefulness of a simple run-in period to reduce drop-outs in a behavioral intervention to improve blood pressure (BP). In a pilot study where a run-in period was not used, we had a 25% drop-out rate.
A prospective evaluation was performed in the context of a blinded 3-arm randomized trial. Participants are eligible if they have uncontrolled BP on 2 consecutive visits. Potential participants are approached during a routine visit, informed, consented and enrolled. After a 1-month run-in period during which all participants receive a phone call to: i) verify phone availability, ii) get basic information on treatment, and iii) confirm the baseline visit, participants return for a baseline visit. They are then randomized to one of the three treatment arms: usual care, non-tailored counseling, or tailored counseling. Participants make return visits at 3, 6 and 12 months.
Of the 1275 potential participants who received detailed study information, 301 consented to participate, of whom 226 were enrolled. During the run-in period, 73 withdrew consent and 153 participants were randomized; 7 subsequently dropped out. There were no differences (p>.1) between the 73 cancelled and the 153 randomized patients. There were fewer drop-outs than in the pilot study (5% vs. 25%, p<.0001).
The run-in period reduces the number of drop-outs after randomization and improves statistical power. In order to retain external validity, it is important to compare participants who remain in the study and those that cancel, and incorporate that in generalizing from the study.
我们评估了一个简单的导入期在一项旨在改善血压(BP)的行为干预中减少退出情况的有效性。在一项未使用导入期的试点研究中,我们的退出率为25%。
在一项三臂双盲随机试验的背景下进行了前瞻性评估。如果参与者在连续两次就诊时血压未得到控制,则符合入选条件。在常规就诊期间接触潜在参与者,向其提供信息、征得同意并进行招募。在为期1个月的导入期内,所有参与者都会接到一个电话,目的是:i)确认电话是否可用,ii)获取治疗的基本信息,iii)确认基线就诊,之后参与者返回进行基线就诊。然后他们被随机分配到三个治疗组之一:常规护理、非个性化咨询或个性化咨询。参与者在3个月、6个月和12个月时进行回访。
在1275名收到详细研究信息的潜在参与者中,301人同意参与,其中226人被招募。在导入期,73人撤回同意,153名参与者被随机分组;随后有7人退出。73名取消参与的患者和153名随机分组的患者之间没有差异(p>.1)。退出的人数比试点研究中少(5%对25%,p<.0001)。
导入期减少了随机分组后的退出人数,并提高了统计效能。为了保持外部效度,比较留在研究中的参与者和取消参与的参与者,并将其纳入研究的推广中很重要。